Danyelza Injection
Product Images NDC 50633-230

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Danyelza (NDC 50633-230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Btg International Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Packaging label for DANYELZA (naxitamab-gqgk) Injection, 40 mg/10 mL (4 mg/mL), indicated for intravenous infusion after dilution. The label includes warnings to discard unused portions and states no preservative is present. Manufactured by BTG International Inc., the label also advises storing refrigerated at 2°C to 8°C (36°F to 46°F) and protecting the vial from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.